yaluronic acid as a skin quality booster: An expert panel consensus.J Drugs Dermatol.2018;17(1):83–88

Humphrey CD & Lawrence AC. Implications of Ozempic and other GLP-1 receptor agonists for facial plastic surgeons.Facial Plast Surg.2023;39:719- 72

Qin J. Ozempic face: A new challenge for facial plastic surgeons.JPRAS. 2023;81:97-98

Galderma. Data on file. MA-57232 [Updated]. 77 Million treated

Galderma. Data on file. MA-55607. Restylane®27 years data publications analysis

Fabi SG, et al. The potential role of biostimulators/dermal fillers to address menopause-related skin conditions. Poster presented at IMCAS 2026; January 29-31, 2026; France

Lorenc ZP, et al. Synergistic efficacy and safety of poly-L-lactic acid biostimulator and hyaluronic acid filler for facial fullness post weight loss due to glucagon-like peptide-1 receptor agonist medication. Presented at the ASDS 2025 Annual Meeting; November
=*=*=*=*=*=
当前为第12/15页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页